RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...
Investors are seeking to protect portfolios from the potential economic fallout from President Donald J. Trump’s tariff plans even as many on Wall Street doubt the situation will erupt into a ...
Base Metal Prices Mixed as Trade Tensions Continue to Unnerve Market -- Market Talk 0950 GMT - Base metal prices are mixed, with LME three-month copper flat at $9,174 a metric ton and LME three-month ...
Platinum Equity has sold Livingston International, a Toronto-based international trade services company specializing in customs brokerage, freight forwarding and trade consulting. No financial terms ...
RBC Capital analyst Daniel Perlin maintained a Buy rating on PayPal Holdings (PYPL – Research Report) yesterday and set a price target of ...
RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The ...
Hosted on MSN22h
Do Wall Street Analysts Like Morgan Stanley Stock?Valued at a market cap of $221 billion, Morgan Stanley (MS) is a New York-based investment bank and financial services firm ...
Management provided 2025 guidance, expecting ARR of $737 million to $745 million, representing 15% to 16% growth. Revenue is projected between $610 million and $625 million, indicating 11% to 13% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback